Crossref
Vaccine therapy in solid tumors (mRNA, TIL, CAR). Is there a breakthrough?
Practical oncology · 30.03.2026 · v. 27 (1) · 52-62
DOI: 10.31917/2701052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical oncology, online erschienen am 30.03.2026. Verfasst von N.M. Volkov.
Abstract (Originalsprache)
immunotherapy, T-lymphocyte, tumor-infiltrating lymphocytes, vaccines, malignant tumors, CAR.
Zitieren
APA
Volkov, N. (2026). Vaccine therapy in solid tumors (mRNA, TIL, CAR). Is there a breakthrough?. Practical oncology, v. 27(1), 52-62. https://doi.org/10.31917/2701052
Vancouver
Volkov N. Vaccine therapy in solid tumors (mRNA, TIL, CAR). Is there a breakthrough?. Practical oncology. 2026;v. 27(1):52-62. doi:10.31917/2701052
BibTeX
@article{Volkov2026,
author = {Volkov, N.M.},
title = {Vaccine therapy in solid tumors (mRNA, TIL, CAR). Is there a breakthrough?},
journal = {Practical oncology},
year = {2026},
volume = {v. 27},
number = {1},
pages = {52--62},
doi = {10.31917/2701052}
}
EUVIMED